Liqiang Xi
National Institutes of Health(US)Thales (Australia)(AU)National Cancer Institute(US)Center for Cancer Research(US)National Institutes of Health Clinical Center(US)Stanford University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lymphoma Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics
Most-Cited Works
- → MicroRNA expression profiles of esophageal cancer(2008)389 cited
- → Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma(2019)367 cited
- → Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia(2017)338 cited
- → MGMT Status as a Clinical Biomarker in Glioblastoma(2020)326 cited
- → Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study(2017)281 cited
- → EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment(2015)279 cited